Thailand has revised its classification of narcotic drugs through updated regulatory notifications, reinforcing control over controlled substances in domestic and international trade.
Thailand Tightens Rules on Schedule IV Narcotics
New classifications affect imports and distribution of specific controlled substances.
What changed
Schedule IV classification updated under formal notification No. 3 B.E. 2568 (2025).
Draft criteria proposed for Schedule IV narcotic drugs effective from the distribution date.
HS code 293941 is the specific product category targeted by these measures.
Who it affects
International importers of HS code 293941 must adhere to new Schedule IV controls.
Domestic distributors of controlled substances must comply with updated classification criteria.
Key dates
Regulation Analysis: Thailand’s Revised Classification of Piperonal as a Schedule IV Narcotic Drug
Thailand has amended its classification of piperonal under the Narcotics Code to introduce specific exemptions for industrial use while maintaining strict controls to prevent diversion for illicit purposes. Piperonal was previously classified as a Schedule IV narcotic drug without exemptions, but the Notification of the Ministry of Public Health RE: Classification of Schedule IV Narcotic Drugs (No. 3) B.E. 2568 (2025) now permits its use in certain products under defined concentration thresholds1.
Key Provisions of the Amendment
- General Classification
Piperonal remains classified as a Schedule IV narcotic drug under Thailand’s Narcotics Code, subject to regulatory oversight by the Food and Drug Administration (Thai FDA), Narcotics Control Division1.
- Exemption Conditions
Piperonal is exempted from Schedule IV classification when used in the following products, provided it meets the specified concentration limits:
- Flavouring agents for food products, cosmetics, or hazardous substances intended for household or public health use:
- ≤ 10% concentration: Exempted from Schedule IV classification1.
- ≤ 1% concentration: Exempted from Schedule IV classification, with no additional restrictions1.
- Objective of the Amendment
The revision aims to:
- Facilitate legitimate industrial use of piperonal in food, cosmetics, and household products1.
- Prevent diversion for illicit drug manufacturing by maintaining regulatory oversight for higher concentrations1.
- Ensure consumer safety and transparency in product labeling and trade1.
- Regulatory Authority
The Thai FDA, Narcotics Control Division, is responsible for enforcing the classification and exemptions1. The Thai Industrial Standards Institute (TISI) serves as the WTO/TBT Enquiry Point for inquiries related to the notification1.
- Effective Dates
Compliance Requirements for Businesses
| Regulation | Key Requirement | Threshold/Deadline | Authority |
|---|---|---|---|
| Notification of the Ministry of Public Health (No. 3) B.E. 2568 (2025) | Piperonal in food, cosmetics, or household products is exempt from Schedule IV classification if ≤ 10%1. | ≤ 10% concentration | Thai FDA, Narcotics Control Division |
| Piperonal in the same products is exempt if ≤ 1%1. | ≤ 1% concentration | Thai FDA, Narcotics Control Division | |
| All other uses of piperonal remain classified as Schedule IV narcotic drugs1. | N/A | Thai FDA, Narcotics Control Division | |
| WTO/TBT Notification (G/TBT/N/THA/798) | Businesses must comply with the revised classification by the entry into force date1. | 13 September 2025 | Thai FDA, TISI |
Summary Answer
Thailand’s Notification of the Ministry of Public Health RE: Classification of Schedule IV Narcotic Drugs (No. 3) B.E. 2568 (2025) amends the classification of piperonal to exempt its use in food products, cosmetics, and hazardous substances for household or public health use, provided the concentration does not exceed 10% (or 1% for broader exemptions)1. The amendment balances industrial utility with regulatory control to prevent illicit diversion, effective 13 September 20251. The Thai FDA, Narcotics Control Division, enforces these provisions, while the Thai Industrial Standards Institute (TISI) handles related inquiries1. Businesses must ensure compliance with the concentration thresholds to avoid classification as a Schedule IV narcotic drug1.
Sources
- ↩ Committee on Technical Barriers to Trade – Notification – Thailand – Narcotic drugs https://docs.wto.org/dol2fe/Pages/SS/directdoc.aspx?filename=Q:/G/TBTN25/THA798.pdf&Open=True